Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MIMEDX to Participate in Upcoming Investor Conferences
-
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
-
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th
-
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
-
Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
-
Panda Express® Drops Taiwanese Popcorn Chicken with Limited-Edition Frankie Gaw Collectible Bucket in Select Test Markets
-
Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer
-
OFA Group Launches PlanAId, Bringing AI-Assisted Building Code Intelligence Earlier Into the Design Process
-
TruGolf Announces Binding Distribution MOU with TruGolf Canada Inc. Covering Defined Canadian and Indigenous Market Opportunities
-
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
QNB Corp. Announces the Execution of a Strategic Repositioning
-
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
-
Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program
-
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET
-
Uniti Wholesale Boosts U.S.-Mexico and Southwest Data Center Connectivity
-
Collegium to Participate in Upcoming Investor Conferences
-
Phillips Edison & Company to Present at BofA Securities 2026 Global Real Estate Conference
-
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today
-
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
-
eQ Plc Members of the Shareholders’ Nomination Committee
-
Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference
-
Alm. Brand A/S – Weekly report on share buybacks
-
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
-
Dynamic Creatures Emerges from Stealth to Launch New Category of Mobile, Interactive Character Robots for Hospitality and Entertainment
-
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
-
Oportun Names Bill Franklin as Chief Financial Officer
-
3 E Network Outlines Full-Stack AI Storage Strategy Across Memory, SSDs and All-Flash Servers
-
AGM Group and HashBeaver Jointly Develop Desktop DePIN Node for Bitcoin Mining
-
WEEX returns to TOKEN2049 Singapore as platinum sponsor, as trading moves beyond crypto
-
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
-
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
-
Brixton Metals Reports Consistent Silver Grades Across All 85 Holes from Maiden Tailings Drill Program at the Langis Silver Project
-
Volatus Aerospace Qualifies Across All Five Streams of Canada’s Defence Drone Initiative Marketplace
-
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
-
BioVie Announces Update to Parkinson’s Phase 3 Development Program
-
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
-
New Flyer awarded Buy America-compliant order from Denver RTD supporting U.S. manufacturing and East Colfax BRT
-
SalesCloser Enters Collaboration Agreement with Tendril to Combine Autonomous AI Engagement and Human-Assisted Outbound Dialing
-
Domestic Metals Commences Drill Program at Smart Creek Project, Montana
-
GE Aerospace to Acquire Consolidated Precision Products (CPP), Expanding Mission-Critical Castings Capacity
-
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
-
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
-
Euro Sun Mining Announces Non‑Binding MoU for US$400 Million Senior Debt Facility and Term Sheet for US$3 Million Strategic Equity Investment
-
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
-
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
-
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
-
CervoMed to Participate in September Investor Conferences
